Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?
Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur GraphSearch.
Concept
David Ho
Résumé
David Da-i Ho (; born November 3, 1952) is a Taiwanese-American AIDS researcher, physician, and virologist who has made a number of scientific contributions to the understanding and treatment of HIV infection. He championed for combination anti-retroviral therapy instead of single therapy, which turned HIV from absolute terminal disease into a chronic disease.
He is the founding scientific director of the Aaron Diamond AIDS Research Center and the Clyde and Helen Wu Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons.
David Ho was born in Taichung, Taiwan, to Paul (), an engineer, and Sonia Ho (née Jiang) ().
David Ho attended Taichung Municipal Guang-Fu Elementary School until sixth grade before immigrating to the United States with his mother and younger brother to unite with his father, who had already been in the US since 1957. He grew up in Los Angeles and graduated from John Marshall High School. He received his Bachelor of Science in biology with highest honors from the California Institute of Technology (1974) and MD from the Harvard-MIT Division of Health Sciences and Technology (1978). Subsequently, he did his clinical training in internal medicine and infectious diseases at UCLA School of Medicine (1978–1982) and Massachusetts General Hospital (1982–1985), respectively. He was a resident in internal medicine at Cedars-Sinai Medical Center in Los Angeles in 1981 when he came into contact with some of the first reported cases of what was later identified as AIDS.
Ho has been engaged in HIV/AIDS research since the beginning of the pandemic, initially focusing on clinical virology and select topics in HIV pathogenesis, including HIV drug resistance. Before 1996, AZT and other early 1990s antiretroviral medication were prescribed in single therapy, which still did not prevent progression to fatal full-blown AIDS. In the mid 1990s, his research team conducted a series of elegant human studies to elucidate the dynamics of HIV replication in vivo.
Source officielle
À propos de ce résultat
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.